Mesa Laboratories, Inc. (MLAB)
NASDAQ: MLAB · Real-Time Price · USD
129.94
-1.04 (-0.79%)
Sep 30, 2026, 4:00 PM EDT - Market closed
Mesa Laboratories Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 727 | 489 | 645 | 592 | 934 | 1,337 | |
Market Cap Growth | 104.88% | -24.23% | 8.93% | -36.64% | -30.14% | 7.00% |
Enterprise Value | 856 | 639 | 824 | 805 | 1,102 | 1,525 |
Last Close Price | 129.94 | 88.17 | 117.44 | 108.04 | 171.07 | 248.66 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 150.94 | 72.78 | - | - | 1004.45 | 714.64 |
Forward PE | 58.66 | 63.76 | 16.50 | 17.53 | 27.40 | 39.18 |
PS Ratio | 2.91 | 1.96 | 2.68 | 2.74 | 4.26 | 7.25 |
PB Ratio | 3.85 | 2.62 | 4.03 | 4.07 | 2.37 | 3.40 |
P/FCF Ratio | 13.75 | 12.34 | 15.15 | 14.24 | 39.85 | 38.43 |
P/OCF Ratio | 13.06 | 11.41 | 13.77 | 13.41 | 33.38 | 34.09 |
PEG Ratio | - | 3.88 | 3.88 | 5.14 | 5.14 | 5.14 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.43 | 2.57 | 3.42 | 3.72 | 5.03 | 8.27 |
EV/EBITDA Ratio | 18.84 | 15.29 | 19.58 | 22.83 | 30.23 | 51.23 |
EV/EBIT Ratio | 38.09 | 34.52 | 46.91 | 218.36 | 331.90 | 324.36 |
EV/FCF Ratio | 16.19 | 16.14 | 19.36 | 19.37 | 47.01 | 43.84 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.86 | 0.91 | 1.21 | 1.59 | 0.49 | 0.58 |
Debt / EBITDA Ratio | 3.05 | 3.45 | 4.04 | 5.76 | 4.68 | 7.11 |
Debt / FCF Ratio | 3.05 | 4.26 | 4.56 | 5.57 | 8.19 | 6.57 |
Net Debt / Equity Ratio | 0.68 | 0.75 | 1.03 | 1.38 | 0.40 | 0.46 |
Net Debt / EBITDA Ratio | 2.84 | 3.36 | 3.91 | 5.71 | 4.36 | 6.02 |
Net Debt / FCF Ratio | 2.44 | 3.54 | 3.87 | 4.84 | 6.78 | 5.15 |
Asset Turnover | 0.58 | 0.58 | 0.55 | 0.39 | 0.32 | 0.28 |
Inventory Turnover | 3.23 | 3.51 | 3.06 | 2.43 | 2.88 | 4.21 |
Quick Ratio | 1.16 | 1.17 | 0.43 | 1.56 | 1.74 | 1.89 |
Current Ratio | 1.79 | 1.72 | 0.63 | 2.47 | 2.74 | 2.59 |
Return on Equity (ROE) | 2.66% | 3.88% | -1.29% | -94.36% | 0.24% | 0.47% |
Return on Assets (ROA) | 3.29% | 2.69% | 2.50% | 0.42% | 0.30% | 0.45% |
Return on Invested Capital (ROIC) | 3.58% | 3.18% | -1.73% | 0.82% | 0.59% | 0.57% |
Return on Capital Employed (ROCE) | 6.20% | 5.10% | 6.50% | 0.90% | 0.50% | 0.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.66% | 1.37% | -0.31% | -42.95% | 0.10% | 0.14% |
FCF Yield | 7.27% | 8.10% | 6.60% | 7.02% | 2.51% | 2.60% |
Dividend Yield | 0.49% | 0.73% | 0.55% | 0.59% | 0.37% | 0.26% |
Payout Ratio | 74.35% | 52.49% | - | - | 366.24% | 178.46% |
Buyback Yield / Dilution | -3.27% | -2.66% | -0.65% | -0.47% | -0.49% | -4.12% |
Total Shareholder Return | -2.78% | -1.93% | -0.10% | 0.13% | -0.11% | -3.86% |